Atrial fibrillation and venous thromboembolism. a Swedish nationwide registry study on 1358274 individuals.

Higher risk of dementia without oral anticoagulation in atrial fibrillation

Anticoagulant use and associated outcomes in patients with atrial fibrillation and advanced kidney disease

Age and gender differences in stroke and bleeding risks in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants

Similar long-term risk of thromboembolic events in postoperative atrial fibrillation following coronary artery bypass grafting and non-valvular atrial fibrillation: need for anticoagulation?

Incidence, predictors and prognosis of thrombus formation on device in patients with atrial fibrillation after left atrial appendage occlusion for stroke prevention in a multicenter analysis.

Edoxaban versus warfarin in patients with atrial fibrillation in relation to stroke risk. A subanalysis of the ENGAGE AF-TIMI 48 study

Fatal and non-fatal secondary events in 496173 individuals with a first episode of atrial fibrillation between 1987 and 2013- a Swedish register study

Comparison of stroke and major bleeding risk of treatment with apixaban vs. rivaroxaban and dabigatran among elderly nonvalvular atrial fibrillation patients in the United States

Correlation of the CHADS2, CHA2DS2-Vasc and ATRIA risk scores with the presence of left atrial appendage thrombus in patients with non-valvular atrial fibrillation.